Canadian Cancer Trials Group Bulletins

Trial Management Group


Distribution of IMP for Canadian Cancer Trials Group

Investigational Medicinal Products (IMP) for some Canadian Cancer Trials Group trials were originally distributed by Investigational Drug Research Services (IDRS) located at the Kingston General Hospital. IDRS ceased deliveries for Canadian Cancer Trials Group trials as of December 31st, 2010.

Drug distribution for affected trials has now been outsourced to Bay Area Research Logistics in Hamilton Ontario. Ordering information for these studies has been communicated to participating sites. Updated drug order forms are available on trial websites at: http://www.ctg.queensu.ca.

This change in distributor also affects trials for which site stock levels are automatically controlled (CO.20, BR.26, BR.29 and MAP.3); however, no change to site procedures is required. Trials sourced from other distributors (i.e. US Pharmaceutical Management Branch) are unaffected.

If you have any questions about this process please contact the SC for your trial or Andrew Dowker (IMP Coordinator) at adowker@ctg.queensu.ca.